BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16290997)

  • 1. Indications for internal cardioverter defibrillator implantation predict time to first shock and the modulating effect of beta-blockers.
    Hreybe H; Bedi M; Ezzeddine R; Barrington W; Jain S; Ngwu O; Saba S
    Am Heart J; 2005 Nov; 150(5):1064. PubMed ID: 16290997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal insufficiency predicts the time to first appropriate defibrillator shock.
    Hreybe H; Ezzeddine R; Bedi M; Barrington W; Bazaz R; Ganz LI; Jain S; Ngwu O; London B; Saba S
    Am Heart J; 2006 Apr; 151(4):852-6. PubMed ID: 16569548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of beta-blockers in patients with an implantable cardioverter defibrillator.
    LaPointe NM; Stafford JA; Pappas PA; Al-Khatib SM; Anstrom KJ
    Ann Pharmacother; 2009 Jul; 43(7):1189-96. PubMed ID: 19567655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of outcomes for patients receiving implantable cardioverter defibrillators for primary vs secondary-prevention.
    Giedrimas A; Giedrimiene D; Guertin D; White CM; Clyne CA; Kluger J
    Conn Med; 2008; 72(6):329-33. PubMed ID: 18610705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group.
    Pacifico A; Hohnloser SH; Williams JH; Tao B; Saksena S; Henry PD; Prystowsky EN
    N Engl J Med; 1999 Jun; 340(24):1855-62. PubMed ID: 10369848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
    Ho AT; Pai SM; Timothy P; Pai RG
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
    Chen HA; Hsia HH; Vagelos R; Fowler M; Wang P; Al-Ahmad A
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An "aggressive" protocol of programmed ventricular stimulation for selecting post-myocardial infarction patients with a low ejection fraction who may not require implantation of an automatic defibrillator.
    Belhassen B; Ohayon-Tsioni T; Glick A; Viskin S
    Isr Med Assoc J; 2009 Sep; 11(9):520-4, 526, 528. PubMed ID: 19960844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of advanced heart failure symptoms to risk of inappropriate defibrillator shocks.
    Hreybe H; Ezzeddine R; Barrington W; Bazaz R; Jain S; Ngwu O; Saba S
    Am J Cardiol; 2006 Feb; 97(4):544-6. PubMed ID: 16461053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.
    Ambardekar AV; Allen LA; Lindenfeld J; Lowery CM; Cannon AP; Cleveland JC; Brieke A; Sauer WH
    J Heart Lung Transplant; 2010 Jul; 29(7):771-6. PubMed ID: 20347337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
    Otmani A; Trinquart L; Marijon E; Lavergne T; Waintraub X; Lepillier A; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Aug; 158(2):230-237.e1. PubMed ID: 19619699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
    Martinelli M; de Siqueira SF; Sternick EB; Rassi A; Costa R; Ramires JA; Kalil Filho R
    Am J Cardiol; 2012 Oct; 110(7):1040-5. PubMed ID: 22727179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICD implantation and arrhythmia-free survival in patients with depressed LV function following surgery for valvular heart disease.
    Yang F; Shah B; Iwai S; Markowitz SM; Lerman BB; Stein KM
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1419-24. PubMed ID: 18950299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study.
    Khairy P; Harris L; Landzberg MJ; Fernandes SM; Barlow A; Mercier LA; Viswanathan S; Chetaille P; Gordon E; Dore A; Cecchin F
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):250-7. PubMed ID: 19808416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.
    Lemola K; Khan R; Nattel S; Talajic M; Roy D; Guerra PG; Lemola S; Dubuc M; Thibault B; Macle L; Khairy P
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):99-105. PubMed ID: 19140919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: impact of left ventricular function.
    Schaer BA; Ammann P; Sticherling C; Zellweger MJ; Cron TA; Osswald S
    Int J Cardiol; 2006 Mar; 108(1):26-30. PubMed ID: 16516695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of the adrenergic system and implantable cardioverter-defibrillator therapies in patients with heart failure.
    Chemello D; Rohde LE; Santos KG; Silvello D; Goldraich L; Pimentel M; Rosa PR; Zimerman L; Clausell N
    Europace; 2010 May; 12(5):686-91. PubMed ID: 20185488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
    Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM
    J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery.
    O'Neill JO; Starling RC; Khaykin Y; McCarthy PM; Young JB; Hail M; Albert NM; Smedira N; Chung MK
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1250-6. PubMed ID: 16256775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.